| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
1,020
|
1,016
|
976
|
988
| | Cost of Revenue | 842 | 851 | 791 | 806 | | |
Gross Profit
|
178
|
165
|
185
|
182
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative | 409 | 406 | 340 | 365 |
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
| 34 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
(231)
|
(241)
|
(155)
|
(217)
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 311 | 363 | 1,727 | 104 |
|
Earnings Before Interest And Taxes | 80 | 122 | 1,572 | (113) |
|
Interest Expense | 49 | 38 | 52 | 56 |
|
Income Before Tax | 31 | 84 | 1,520 | (169) |
|
Income Tax Expense |
-
|
-
|
-
|
-
|
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 370 | 84 | 1,520 | (169) | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
370
|
84
|
1,520
|
(169)
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
31
|
84
|
1,520
|
(169)
|
|